Trial Offers Hope for Cheaper, More Tolerable, Ketamine Treatment
June 25, 2024
June 25, 2024
DUNEDIN, New Zealand, June 25 (TNSres) -- The University of Otago issued the following news release:
For those suffering from treatment-resistant depression, the anaesthetic drug ketamine offers hope, but it has side effects and can be costly to access - a University of Otago-led clinical trial may change that.
Working in collaboration with New Zealand's Douglas Pharmaceuticals, researchers have conducted a trial of ketamine in an extended-release tablet form.
For those suffering from treatment-resistant depression, the anaesthetic drug ketamine offers hope, but it has side effects and can be costly to access - a University of Otago-led clinical trial may change that.
Working in collaboration with New Zealand's Douglas Pharmaceuticals, researchers have conducted a trial of ketamine in an extended-release tablet form.